Envoy Medical, Inc.
COCH
$1.14
-$0.01-0.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -26.49% | -28.62% | -28.80% | 15.35% | 38.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.49% | -28.62% | -28.80% | 15.35% | 38.53% |
| Cost of Revenue | -2.07% | 10.43% | -2.37% | 20.97% | 38.22% |
| Gross Profit | -12.14% | -36.73% | -16.44% | -24.08% | -38.03% |
| SG&A Expenses | -8.84% | -13.79% | -4.39% | 50.44% | 54.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.24% | -0.51% | 4.20% | 46.86% | 52.96% |
| Operating Income | 0.85% | 0.08% | -4.77% | -47.39% | -53.20% |
| Income Before Tax | -56.96% | 14.55% | 30.29% | 42.13% | 65.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.96% | 14.55% | 30.29% | 42.13% | 65.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.96% | 14.55% | 30.29% | 42.13% | 65.54% |
| EBIT | 0.85% | 0.08% | -4.77% | -47.39% | -53.20% |
| EBITDA | 1.32% | 0.39% | -4.58% | -47.32% | -53.25% |
| EPS Basic | -63.01% | 25.90% | 45.34% | 61.20% | 76.92% |
| Normalized Basic EPS | 4.46% | 53.76% | 50.18% | 54.54% | 49.60% |
| EPS Diluted | -61.74% | 26.01% | 45.36% | 61.22% | 76.65% |
| Normalized Diluted EPS | 1.95% | 53.15% | 49.54% | 53.99% | 50.89% |
| Average Basic Shares Outstanding | 18.96% | 31.62% | 48.76% | 86.13% | 63.33% |
| Average Diluted Shares Outstanding | 17.18% | 29.37% | 45.80% | 81.65% | 65.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |